Nenter & Co., Inc. is a wholly-owned subsidiary of a listed company named GuanFu joint stock company (stock code:002102). Our company was founded in 2006, and the registered capital was RMB 220 million. Currenty, we have 3 production plants, which covers approximately 139 acres in total. The existing total assets of Nenter are nearly RMB 1.8 billion and the sales revenue reached RMB 950 million in 2017. We have more than 1000 employees and more than 100 technical staffs. Nenter is a high-tech enterprise producing, developing, and selling medical intermediates, fine chemical and feed additives. Now we have two products series. The first one is a series of medical intermediates, and the main products are montelukast sodium intermediates for the treatment of asthma and anti-allergic, and rosuvastatin intermediates for the treatment of hyperlipidemia and high cholesterol. The second one is a series of Vitamins which developed from Vitamin E and its intermediates.  In order to guarantee the quality of our products, we built up quality management system according to GMP system step by step, and up to now, we've obtained cerfificates of ISO9001:2008, PMDA, USFDA(serial number:030521), and FAMI-QS. Nenter wiil lead its products into leading products of global production capacity, market share and quality, and form the core competitiveness of the company, thus Nenter will become a stronger enterprise.